100 mL of FectoVIR®-AAV transfection reagent is sufficient to transfect on average 50 L of cell culture 100 mL的FectoVIR®-AAV 至少转染50 L培养液
Storage 储存条件
5 ± 3 °C, stable for at least 9 months when stored appropriately 5 ± 3 °C, 至少18 个月
Provided with 配套提供
Protocol Certificate of Analysis Certificate of Origin Non-Hazardous Product Statement 操作说明书 COA分析报告 无动物来源声明 无危害声明
Summary(总结)
AAVs are becoming the leading viral vector in the development of gene-based advanced therapy medicinal products (ATMPs). Their success is due to their intrinsic properties: they are primarily non-integrating as they persist within cells as episomes, and have a broad tropism with eleven serotypes that have the ability to infect specific cell types. A major challenge today is manufacturing sufficient quantities of AAV in order to treat larger groups of patients. FectoVIR®-AAV is a novel class of animal free transfection reagent specifically developed for industrial scale production of recombinant AAV (rAAV) viral vectors in suspension HEK-293 cell types. FectoVIR®-AAV transfection reagent guarantees higher rAAV viral titers, improved flexibility and scalability for industrial scale manufacturing. aav正在成为基于基因的先进治疗药物(ATMPs)开发的主要病毒载体。它们的成功是由于它们的内在特性:它们主要是不整合的,因为它们以集集体的形式存在于细胞内,并具有广泛的趋同性,具有感染特定细胞类型的能力的11种血清型。今天的一个主要挑战是生产足够数量的AAV,以治疗更大的患者群体。FectoVIR®-AAV是一种新型的动物无转染试剂,专门开发用于工业规模生产重组AAV (rAAV)病毒载体悬浮HEK-293细胞类型。FectoVIR®-AAV转染试剂保证了更高的rAAV病毒滴度,提高了工业规模生产的灵活性和可扩展性。
A Frequently Asked Question section about FectoVIR®-AAV can be found here. 关于FectoVIR®-AAV的常见问题可以在这里找到。 Read FAQ(阅读常见问题)